Does UBLITUXIMAB Cause Nasopharyngitis? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Nasopharyngitis have been filed in association with UBLITUXIMAB (BRIUMVI). This represents 2.3% of all adverse event reports for UBLITUXIMAB.
37
Reports of Nasopharyngitis with UBLITUXIMAB
2.3%
of all UBLITUXIMAB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Nasopharyngitis From UBLITUXIMAB?
Of the 37 reports, 1 (2.7%) resulted in death, 3 (8.1%) required hospitalization.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for UBLITUXIMAB.
What Other Side Effects Does UBLITUXIMAB Cause?
Infusion related reaction (538)
Fatigue (110)
Headache (55)
Inappropriate schedule of product administration (53)
Malaise (49)
Multiple sclerosis relapse (48)
Asthenia (45)
Pain (45)
Illness (43)
Urinary tract infection (42)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which UBLITUXIMAB Alternatives Have Lower Nasopharyngitis Risk?
UBLITUXIMAB vs UBLITUXIMAB-XIIY
UBLITUXIMAB vs UBROGEPANT
UBLITUXIMAB vs ULIPRISTAL
UBLITUXIMAB vs UMBRALISIB
UBLITUXIMAB vs UMECLIDINIUM